Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
Simiao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Pascal Geldsetzer(Stanford University), Klaus Prettner(Vienna University of Economics and Business), David E. Bloom(Harvard University), Juntao Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Michael Kühn(University of Vienna), Lirui Jiao(Columbia University), Weimin Li(Sichuan University), Till Bärnighausen(Harvard University), Zhuoran Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhong Cao(Beijing Academy of Artificial Intelligence)
Cited by 822
Related Papers
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
|JAMA|2017|2.4k
Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Neurology|2017|2.3k
The Global Economic Burden of Noncommunicable Diseases
|WU Research|2012|2k